Product
Help
Pricing
About
Jobs
Log in
Get started
Award
Add to collection
82272762
Funder:
National Natural Science Foundation of China
Funded outputs count:
7
Funder award ID:
82272762
OpenAlex ID:
G1179198033
Chemotherapy-induced senescence promotes stroma stiffness and antioxidant adaptation to promote chemoresistance in pancreatic ductal adenocarcinoma
2026
·
Xinxin Liu
, Zhihua Huang
, et al.
·
Nature Communications
·
1
The BTN3A3-TOMM22 axis preserves mitochondrial homeostasis to facilitate HCC stemness and drug resistance
2026
·
Xiaofeng Kang
, Guanglin Lei
, et al.
·
Cancer Letters
·
4
Single-cell profiling reveals distinct populations of tumor-associated macrophages and metastatic tumor cells in breast cancer brain metastasis
2026
·
Haoyuan Shi
, Jiaxin Chen
, et al.
·
Cell Death and Disease
PDF
Dalpiciclib plus chidamide in HR + /HER2−advanced breast cancer after CDK4/6 inhibitor failure: a phase Ib trial
2026
·
Jinmei Zhou
, Xuexue Wu
, et al.
·
Nature Communications
PDF
TIMM10 enhances MAVS mediated innate immune response against influenza A virus infection
2025
·
Chunyuan Xue
, Yimeng Du
, et al.
·
Colloids and Surfaces A Physicochemical and Engineering Aspects
·
2
Microdroplet-enhanced chip platform for high-throughput immunotherapy marker screening from extracellular vesicle RNAs and membrane proteins
2024
·
Chuanhao Tang
, Zaizai Dong
, et al.
·
Biosensors and Bioelectronics
·
5
Hsa-LINC02418/mmu-4930573I07Rik regulated by METTL3 dictates anti-PD-L1 immunotherapeutic efficacy via enhancement of Trim21-mediated PD-L1 ubiquitination
2023
·
Zhijia Sun
, Haixing Mai
, et al.
·
Journal for ImmunoTherapy of Cancer
·
48
PDF
Show more works
View as search
Year
Topic